Tag

Latest News
    The NIIM has made an announcement on changes to the AP approval process with the following implications: Brand-based HREC approvals will move to schedule-based approvals Via an amendment form, healthcare professionals will be able to switch to the new system   Inter alia, the announcement reads: “The TGA would accept ethics approvals for...
Hemp can capture twice as much carbon as forests whilst providing raw material for carbon-negative biomaterials “Numerous studies estimate that hemp is one of the best CO2-to-biomass converters”, said Darshil Shah, a researcher at Cambridge University, in a recent interview with Dezeen. The plant is a variation of the Cannabis sativa plant, which contains very...
In the US, one-third of all states where cannabis laws have been eased have done so in the last 6 months alone. Cannabis laws around the globe have traditionally been very conservative in the past, as the plant and its influence on the human body were not yet well understood. However, with an ever-growing body...
Banking politics are stifling Jamaica’s unique opportunity to foster a medicinal cannabis industry. It’s reassuring to see senior members of the Jamaican government engaging with the industry to actively find solutions to these significant problems. Full article link here
With the demand for CBD so high, sub-par products have been flooding the market. It is incredibly important to source from businesses with stringent testing around growing and manufacturing. Full article here 
Given the popularity of CBD, biotech firms are attempting to synthesis CBD to meet expanding demand. Synthesised CBD would lack the entourage effect of natural CBD, so it will be interesting to see how the efficacy of these alternatives stacks up. Full article link here
With 25% of 192 million people polled across three countries stating that their use is partly medicinal. The market segment of medical cannabis is in for a surge of demand and we are prepared to meet that opportunity. See full article here
The potential for over-the-counter CBD access in Australia has led to questions surrounding the maximum doses permitted. The Lamber Initiative shows that 60 milligrams a day may not be high enough to benefit patients. However, this still creates an opportunity for Cannim to offer Australians the relief they need and remains a space to watch...
The potential for over-the-counter CBD access in Australia has led to questions surrounding the maximum doses permitted. The Lamber Initiative shows that 60 milligrams a day may not be high enough to benefit patients. However, this still creates an opportunity for Cannim to offer Australians the relief they need and remains a space to watch....